Bioentrepreneur Blog


Why A Seasoned Management Team Is The Ultimate Competitive Advantage

by Allan Shaw This article originally appeared in Life Sciences Leaders in November 2015 by Allan L. Shaw is a Senior Biopharmaceutical Executive / Chief Financial Officer: Currently member of the board of directors for Akari Therapeutics (chairman of the audit committee) and VIVUS (chairman of the compensation committee). Recently managing director – life science practice leader for Alvarez & Marsal’s Healthcare Industry Group and formerly CFO of Serono; possessing more than 20 years of corporate […]


Do Outcomes Matter When There Is Chronic Misalignment?

by Allan Shaw This article originally appeared in Life Sciences Leaders in October 2015 by Allan L Shaw member of the board of directors and chairman of the audit committee, Akari Therapeutics, and a board member of VIVUS, Inc. With over $3 trillion in annual healthcare spending, a relatively young population, and shorter life expectancies than other western nations, one would think there would be vast opportunities for the U.S. healthcare industry to rein in costs, weed […]


Becoming an Entrepreneur – Dr. Noel Goddard and Goddard Labs

by Nicholas McKeehan July 2015 – cucumbers were suspected to have caused a salmonella outbreak. It affected 27 states, killed one person, and sickened at least 285 others. April 2013 – cucumbers again were suspect in a salmonella outbreak. This one affected 18 states and sickened 84 people. Late 2011 – cantaloupes were suspected to have caused a listeria outbreak that affected 28 states and killed nearly three-dozen people. These preventable incidents are an unfortunate reminder that current […]


Value & Pricing: Moving Past the Rhetoric in Biopharma

by Allan Shaw This article originally appeared in Life Sciences Leaders in July 2015 by Allan L Shaw member of the board of directors and chairman of the audit committee, Akari Therapeutics, and a board member of VIVUS, Inc. Today we bear witness to a “golden age” for biopharmaceuticals. With all of the exciting/ innovative science, growing scripts, increase in drug approvals, and record revenue, it’s difficult to call it anything else. This is all occurring […]


1st Pitch Preview – October 15 (NY)

By Matthew Murphy This Thursday, October 15, the Mid Atlantic Bio Angels will host their first 1st Pitch NY event of the Fall at the NY Genome Center. The following three companies will each get an opportunity to pitch their ideas to a panel of investors and compete to be named “Best in Show” by the audience. — The improved speed and decreased cost of DNA sequencing has led to a dramatic increase in the […]


Preview: June 1st Pitch in NY

[Originally published on June 1, 2015] On Tuesday, June 2nd, the Mid Atlantic Bio Angels (MABA) will host their fifth 1st Pitch Life Science event of 2015 at the NY Genome Center. The event will feature a brand new segment, “War Stories,” where industry insiders will discuss their personal experiences in life science entrepreneurship. In the first installment, Arthur Klausner will talk about his transition from venture capitalist to his current role as CEO of two biotech companies. Below are […]


Preview: 1st Pitch Comes to New Jersey

[Originally published on May 5, 2015] On Wednesday, May 6, 1st Pitch Life Science will be coming to New Jersey! The event, which is organized by the Mid Atlantic Bio Angels (MABA), will be held at the Institute for Life Science Entrepreneurship (ILSE) on the Keane University campus. Three life science companies will have an opportunity to pitch to a panel of investors and get feedback from both the investors and the audience. At the end of the day, the audience will vote […]


Dr. Gerard Honig on Building a Biotech in NYC

by Nicholas McKeehan [Originally published on April 16, 2015] Last February, Symbiotic Health won “Best in Show” at Mid Atlantic Bio Angels’ 1st Pitch Life Science. The company is developing a capsule that uses bacteriotherapy to treat microbiome diseases such as Clostridium difficile (Cdiff). Symbiotic’s story is compelling, especially for such an early-stage venture with a first time CEO, and, in fact, MABA co-founder and 1st Pitch panelist, Steve Goodman said in a press release, […]